GenSight Biologics
GenSight Biologics is a France-based biopharmaceutical firm that researches and develops gene therapies to treat retinal neurodegenerative diseases and CNS disorders.
Business Model:
Revenue: $8.7M
Employees: 11-50
Rankings
Industries / Tags:
Detailed GenSight Biologics Information
Geographic Data
Address: 74, rue du Faubourg Saint-Antoine
City: Paris
State: île-de-france
Zip: 75012
Country: FR
Financial Info
Stage:
post ipo equity
Raised Last:
$35M
Raised Total:$189M
Social
Metrics
3,406,701Website Global Rank
4,587Website Monthly Traffic
Twitter Followers
Description
GenSight Biologics is a France-based biopharmaceutical firm that researches and develops gene therapies to treat retinal neurodegenerative diseases and CNS disorders.
Contact Phone:
Contact Email:
GenSight Biologics went public on 7/15/2016 on the PA
Listed Exchange:
PA
IPO Date:
7/15/2016
Ticker Symbol:
SIGHT
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
